That's essential, due to the fact that the way a protein in the body folds figures out if a pharmaceutical will be able to bind to that protein and be reliable. Simply put, we need to know how these proteins fold if we desire a drug to work. Historically, this has actually been a trial-and-error process (jeff brown investor prediction). But now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it much easier to create drugs that do what they're developed to do. This was an advancement practically nobody discovered. But it's going to have extensive ramifications for curing illness. I forecast that Alpha, Fold will be 98% precise by the end of 2021.
And, obviously, there will be lots of investment chances in this space, too. Moving subjects It's going to be a great year for bitcoin. I'm bullish on it in 2021 (angel investor). That said, I still think bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be surprised if it drew back possibly substantially prior to going greater - future report. I've been covering bitcoin for a long period of time now. One of the first research study reports I ever published was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial suggestion, I entitled my report "What's the Big Offer With Bitcoin?" That reveals you where the conversation was at the time. We were mainly educating readers. But that's not the huge concern any longer. Now we're seeing institutional money finally take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, specific niche business. Mass, Mutual is a trusted 170-year-old institution. So think of that. In 5 years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
Which's a big reason I'm bullish on it this year. melania trump. Regards, Jeff Brown, Editor, The Bleeding Edge I have a benefit prediction 2020 was a record year for IPOs. 552 U.S. business went public the most in more than twenty years. These business raised a total of $172 billion. That's an all-time high beating the previous annual record by 43%. I forecast 2021 will be another record year in IPOs. There are a lot of great private companies on the edge of hitting the public markets And I have actually been working on a brand-new way for you to invest even before these companies go public.
This chance has actually been building over the last couple of years. I can't wait to tell you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to discover all the information. Go right here to book your area totally free.
Emma Walsh here, managing editor of the Diary. Routine Journal readers understand that tech isn't our usual beat (melania trump). And when it pertains to tech investing, we leave it to the specialists. The good news is, we have a number of such specialists in our Rolodex. Our associate Jeff Brown will be familiar to our long time readers. He is among the most accomplished tech investing professionals we understand (biotech stocks). In truth, he had a number of triple-digit returns in his Brownstone Research portfolios in 2015. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to take a look at the big picture and predict what's just around the corner.
That consists of things like 5G networks, biotech, artificial intelligence, and much more. These patterns are experiencing exponential development and developing amazing opportunities for investors. I wish to make certain all our readers are gotten ready for what's next. And with that in mind, let me draw the photo of what I see can be found in the next 12 months Our new 5G (fifth-generation) cordless networks are a subject I've been covering for years now. the legacy report prediction. However in spite of what numerous readers might believe, this is a pattern that's just getting started. Despite the fact that the COVID-19 pandemic interrupted supply chains in 2015, an excellent 250 million 5G-enabled devices were still offered.
And all of this ultimately caused Apple delaying the release of the 5G-enabled i, Phone 12 by 2 months (jeff brown prediction). Losing two months of production and sales really impacts how lots of 5G gadgets are offered in the calendar year. When you think about all of that, selling 250 million units is impressive. More notably, the hold-ups triggered by the pandemic developed a lots of bottled-up need. And that demand is now going to be pressed into 2021. In truth, I predict that more than 500 million 5G gadgets will be delivered in 2021 - the legacy report prediction. Which's not my only 5G forecast When I have actually spoken about 5G in the past, I have actually described its three various stages.
In Stage 2, 5G devices go on sale. 5G phones and other items begin to reach customers. And in Stage Three, 5G services start to be used (jeff brown stock market prediction). That's when we start to see applications operating on 5G networks. Think about things like huge multiplayer video games over a cellphone. That's not possible with 4G. It will be with 5G. And my second 5G forecast for 2021 is that we will start Phase 3 by this summertime. This starts something of a virtuous cycle: The majority of people don't actually care about the technology. But they will care if there are exciting applications that can just be accessed with a 5G phone.
That causes more 5G apps being developed. In truth, 5G is going to open up a suite of incredible applications: self-driving cars and trucks, the Internet of Things, robotic surgery, and more. All of these innovations need 5G. The investment opportunities moving forward will be massive. Stepping away from 5G, the next important innovation I predict in 2021 is CRISPR genetic editing. CRISPR stands for "clustered routinely interspaced brief palindromic repeat." It's a mouthful. However it is among the most interesting developments in biotechnology. At a high level, CRISPR is a technology that can edit our hereditary makeup as if it were software application.
The program can crash or not work correctly. CRISPR uses a comparable concept however with our hereditary code. "Typos" in our genome can result in disease. CRISPR can remedy these "typos." For many years, CRISPR was primarily a specific niche technology that wasn't well comprehended. And during that time, there were really just 3 companies running in this area. However things are changing. CRISPR is no longer just theoretical. We're seeing actual results. We're dealing with diseases and seeing that this innovation simply works. And as a result, a "second crop" of early-stage CRISPR business is going public and delivering amazing returns. This entire market is successfully a greenfield opportunity.
There's space for many business to exist in this area. tech predictions. And there will be more. That's my prediction for CRISPR in 2021. I forecast that 2 or three more hereditary editing business will hold their IPOs. Sticking to biotechnology, we are seeing amazing things occurring at the merging of biotech and synthetic intelligence (AI). Google's AI subsidiary, Deep, Mind, just revealed at the end of 2020 that its latest Alpha, Fold software application can accurately predict the folding of a protein based solely on its amino acid series with 92. 4% precision. That is essential since the way a protein in the human body folds identifies if a pharmaceutical will be able to bind to that protein and be effective.
Historically, this has actually been a trial-and-error procedure. Now, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it much simpler to develop drugs that do what they're designed to do. And here's my next prediction. I predict that Alpha, Fold will be 98% precise by the end of 2021. And we will see not simply one but numerous drug treatments produced utilizing this innovation. This was among those breakthroughs that almost nobody discovered. However it's going to have profound implications for treating illness. And, naturally, there will be lots of financial investment chances in this space, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That stated, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I would not be amazed if it drew back perhaps substantially prior to going greater. I've been covering bitcoin for a very long time now. Among the very first research reports I ever published was on bitcoin - jeff brown market predictions. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anybody who followed my recommendation. But at the time of that preliminary suggestion, I entitled my report, "What's the Big Deal With Bitcoin?" That reveals you where the discussion was at the time.
However nobody is asking that concern any longer. Now, we're seeing institutional money lastly taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, specific niche enterprise. biotech stock. Mass, Mutual is a 150-year-old institution. So believe about that. In five years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a huge reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another bonus prediction In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown deserves about $27. 5 million and declares the details is up to date as of February 2021, however we might not individually validate this claim. Offered Jeff Brown's past, he likely has a significant net worth, but we can't hammer down a precise figure at this minute. Brown is best understood for his sage-like capability to pick winning innovation stocks. He spent more than 25 years looking into innovation business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience offers him an excellent point of view on the market. He's always on the hunt for new opportunities, and he shares a lot of his best choices in the Near Future Report.
That's full marks, however it's not absurdly reasoned. Brown has an excellent reputation as a stock-picker, and he effectively predicted some of the greatest economic occasions of the past twenty years. Although he doesn't appear to launch his picks to the general public, the service's success is a direct indication of Brown's stock-picking expertise. No one on Wall Street gets it right every time, but Jeff Brown's accurate predictions have actually earned him legions of devoted followers. That states a lot about his ability. The Future Report is published by Brownstone Research study, a prominent financial research study publisher. Brownstone Research uses several research study services with a variety of specializations - jeff brown genome sequencing.
The business is also affiliated with Bonner & Partners, another well-respected research study publisher - angel investor. On its site, Brownstone says its mission is to provide retail investors with professional-grade research study: "For too long, the very best financial investment research has not been offered to specific investors. It has been normally reserved for investment banks, hedge funds, private equity, and high-net-worth customers. first lady. The objective of Brownstone Research study is to make that type of proprietary research study available to any investors aiming to acquire an edge in the marketplaces. The goal is simple to deliver unique and lucrative financial investment research study discovered nowhere else." -Brownstone Research site excerpt from the Jeff Brown is the founder of Brownstone Research, and he also acts as the firm's Chief Investment Expert.
With Brown assisting the ship, Brownstone Research study is a powerhouse publisher with lots to use its customers. After decades of consistent success at the helm of top-tier business like Tesla and Area, X, Elon Musk is a family name throughout the majority of America. If you know even a bit about the market, you understand that he has a track record as a King Midas of sorts. exponential tech investor. Everything he touches relies on gold! Jeff is aware of Elon Musk's executive expertise, so he constantly has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next big job.
In reality, Brown thinks S.A.V. tech stock. could be "the greatest trend of the 2020s, and he's not alone. Examine out these quotes from other popular S.A.V. bulls: Elon's next huge act will be weding 2 cutting-edge technologies: expert system and electric vehicles. Musk hopes the mix will help him develop the first fully-autonomous, self-driving automobiles ever. It's nothing except the automobile industry's Holy Grail. As you know, electrical vehicles and self-driving automobile stocks have actually been huge this year, however the Wall Street device has actually been big on buzz without much tangible result. Despite an extreme increase in competitors over the past few years, Brown still believes Musk has the very best opportunity of putting it all together.
tech might be the magic string that connects all of it together. S.A.V. stands for Shared Autonomous Car, and it might be the future of transport. Basically, this technology would enable you to rent your automobile as an autonomous, self-driving taxi when you're not utilizing it. You just leave the automobile and press a button on an app that tells the vehicle to "sign up with the fleet." Next thing you understand, you're relaxing on your sofa while your vehicle shuttles ride-sharers around town. Best of all, you get to keep a significant piece of the revenues. It sounds crazy, however it could be closed than you think.